Skip to content

Effect of Endoscopic Papillary Large Balloon Dilation on Recurrent Rate of Patients With Recurrentstones in Bile Duct

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02330601
Enrollment
180
Registered
2015-01-05
Start date
2014-06-01
Completion date
2021-06-11
Last updated
2023-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopic Papillary Large Balloon Dilation

Brief summary

The recurrent rate of CBDS in patients with recurrent CBDS is high. It was reported that up to 60% of patients had stone recurrence within two years after stone retrieval by ERCP. Although EPLBD is useful for for extraction of large CBDS with less operation time and mechanical lithotripsy.It is not known whether EPLBD could prevent the recurrence in patients with recurrent CBDS.Although Harada et al found that EPLBD might reduce the short-term recurrence of CBD stones in patients with previous ES. It is a retrospective study with a small sample size (n=94). Here a prospective, randomized controlled study including two tertiary centers was designed. The aim of this study was to investigate whether EPLBD could reduce the recurrence rate in patients with recurrent CBDS.

Interventions

PROCEDUREendoscopic papillary large balloon dilation

For the patients in EPLBD group, a CRE balloon (diameter 10, 11, 12, 13.5, 15 mm; Boston Scientific) was chosen according to the diameter of bile duct. It was placed across the papilla orifice and then gradually filled with diluted contrast. When the waist disappeared, the balloon was kept inflated for 120s. The stones were then retrieved by a basket or a retrieval balloon.Mechanical lithotripsy was used if necessary

Sponsors

Air Force Military Medical University, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18-80 2. Patients with recurrent CBDS after ERCP

Exclusion criteria

1. Benign or malignant CBD stricture 2. Recurrent stone within 3 months after ERCP 3. Previous endoscopic papillary large balloon dilation (EPLBD) 4. Prior surgery of Bismuth II and Roux-en-Y 5. Septic shock 6. Coagulopathy (INR\>1.3), platelet\<50000 or using anti-coagulation drugs 7. With expected life span less than 24 months 8. Pregnant women 9. Refusal or unable to give written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Recurrent rate of CBDS within two years after ERCPup to 2 yearsWithin the two years after ERCP, CBDS was found again by CT, MRCP, ERCP or biliary surgery

Secondary

MeasureTime frame
success rate of stone extractionup to 2 years
success rate of stone extraction in the initial attemptup to 2 years
recurrent timeup to 2 years
rate of mechanical lithotripsyup to 2 years
post-ERCP complicationup to 2 years
performance time of ERCPup to 2 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026